查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1836793

食用動物非治療性抗生素市場（依動物類型、產品類型、最終用途、配方和銷售管道）——全球預測，2025-2032

Non-Therapeutic Antibiotics for Food Animals Market by Animal Type, Product Type, Application Mode, End Use, Formulation, Sales Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，食用動物非治療性抗生素市場將成長至 90.9 億美元，複合年成長率為 7.39%。

主要市場統計數據
基準年2024年 51.3億美元
預計2025年 55.2億美元
預測年份：2032年 90.9億美元
複合年成長率（%） 7.39%

不斷發展的科學、監管和商業性背景的戰略框架，定義了食用動物非治療性抗生素使用的現代方法。

受科學發展、消費者期望變化以及監管審查力度加強的影響，圍繞食用動物生產中非治療性抗生素的全球討論已進入一個更加複雜的階段。價值鏈上的相關人員正在努力協調動物健康管理和抗菌藥物管理原則，同時保持生產力和供應的連續性。本引言為後續分析提供了背景，重點介紹了政策發展、產業反應和商業性現實之間的相互作用。

隨著科學日益揭示抗生素抗藥性及其緩解途徑，生產商和供應商面臨著採用負責任的使用實踐以及替代常規預防和促生長用藥的期望。同時，貿易和投入成本的動態正在影響採購決策，促使供應鏈相關人員重新評估採購彈性和供應商關係。非治療性抗生素的使用不再只是一個獸醫問題，而是一個與法規合規性、品牌聲譽、動物福利和營運韌性相互交織的策略風險和機會。

本執行摘要的其餘部分以此為基礎，研究市場變化、關稅的貿易影響、細分層面的細微差別、區域動態、競爭情報、建議的行動和調查方法，始終檢驗基於證據的決策和組織可以部署的實際步驟，以推進向減少對非治療性抗生素的依賴的轉變，同時保護動物生產力和業務連續性。

科學證據、消費者期望和技術進步如何改變食用動物生產的管理實踐和商業策略

近年來，一系列變革性變化重塑了非治療性抗生素在畜牧生產中的認知、監管和使用方式。首先，科學共識和監測數據已將抗生素抗藥性從一個小眾問題提升為跨部門公共衛生優先事項，促使獸醫和食品安全部門建立更強力的管理框架並修訂指南。因此，行業實踐正在不斷調整，許多大型生產商和零售商正在正式製定抗生素使用政策，並加快替代干預措施的測試。

其次，消費者偏好加劇了商業性壓力。對透明度的要求以及對標籤要求的不斷提高，促使品牌透過抗生素使用聲明進行差異化，推動採購變革，並根據管理目標將產品定位為高階產品。第三，育種、快速診斷和疫苗研發的技術進步正在擴展套件，以減少常規預防性使用，並實現有針對性的治療性介入。然而，這些工具的採用將因生產系統、規模和資本密集度而異。

最後，供應鏈和貿易動態正在同步演變。垂直整合、合約製造模式和零售商主導的採購要求日益成長，而風險管理策略通常將監管軌跡和聲譽風險納入考慮。總而言之，這些轉變對於那些能夠採用基於科學的管理模式、證明供應鏈可追溯性並投資於非治療性抗生素用途的可擴展替代方案的公司來說，既帶來了營運挑戰，也帶來了戰略機會。

評估2025年關稅調整後，整個價值鏈的投入來源、供應彈性和管理投資的營運可行性將如何變化

2025年生效的關稅政策調整進一步加劇了畜牧業相關投入品和最終產品的貿易和供應平衡，影響了成本結構和採購決策，並間接影響了非治療性抗生素的使用模式。某些動物用藥品和飼料原料的關稅改變了相對價格，促使一些生產商重新評估其採購區域，並加速了供應多元化策略。這些貿易變化並非孤立存在，而是與國內監管方式和農場層面的管理選擇相互影響。

對於淨利率微薄或替代投入管道有限的生產商而言，關稅帶來的成本壓力可能會限制對強化管理技術的投資，例如快速診斷、強化生物安全基礎設施和新型疫苗平台。相反，擁有一體化供應鏈和大規模採購的企業可以透過將採購轉向提供符合管理要求的投入的供應商來增強其長期競爭力。關稅對各地區的影響並不均衡，導致反應不對稱，有些供應叢集加速國內替代，而有些則深化與低成本叢集的貿易夥伴關係。

重要的是，關稅變化也影響經銷商和飼料廠的策略。分銷網路正在調整庫存和合約條款以降低波動性，飼料製造商也在重新評估其配方，以便在原料價格波動的情況下保持營養充足。總體而言，2025 年關稅的累積效應正在提高韌性和適應性的策略性溢價，這使得主動的管理投資和供應鏈重新設計對於尋求同時管理合規性和商業績效的相關人員而言比以往任何時候都更加重要。

特定領域的見解揭示了動物類型、產品類別、給藥方法、最終用途、配方形式和分銷管道如何決定管理途徑和採用障礙

細粒度細分顯示，避免常規非治療性抗生素使用的途徑因動物類型、產品類別、應用模式、最終用途、配方和銷售管道而異。根據產品類型，水產養殖、牛、家禽和豬等生產系統具有不同的流行病學、管理節奏和資本需求，這取決於可行的管理干預措施。家禽和豬養殖系統面臨的壓力和機會與家牛和水產養殖不同，因為它們的飼養密度通常較高，生產週期較短。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 受零售商要求和消費者對無抗生素肉品的需求所推動，抗生素管理計畫正在不斷擴大
  • 歐盟和北美正在加強牲畜非治療性抗生素的使用限制
  • 農場微生物組監測創新，最佳化抗生素減少策略
  • 主要家禽市場迅速採用益生菌和植物來源物質等替代生長促進劑
  • 官民合作關係激增，用於資助養豬生產中抗生素替代品的研究
  • 進口商強制實施的無抗生素認證標準正在改變全球肉類貿易的動態

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 食用動物非治療性抗生素市場（依動物類型）

  • 水產養殖
  • 牛
  • 家禽
  • 豬

9. 食用動物非治療性抗生素市場（依產品類型）

  • Aminoglycosides
    • 慶大霉素
    • 新黴素
    • 鏈黴素
  • 大環內酯類
    • 紅黴素
    • 替米考星
    • 泰樂菌素
  • 青黴素
    • 阿莫西林
    • Ampicillin
    • 青黴素G
  • 磺胺類藥物
    • 磺胺嘧啶
    • 磺胺二甲嘧啶
    • 磺胺甲噁唑
  • 四環黴素
    • 四環黴素
    • 四環黴素
    • 四環黴素

10. 食用動物非治療性抗生素市場（依最終用途）

  • 餵食期間
  • 水下

11. 食用動物非治療性抗生素市場（依最終用途）

  • 促進生長
  • 預防

12. 食用動物非治療性抗生素市場（依配方）

  • 飼料添加劑
  • 口服懸浮液
  • 水溶性粉末

13. 食用動物非治療性抗生素市場（依銷售管道）

  • 飼料廠
  • 零售藥局
  • 獸藥經銷商

14. 食用動物非治療性抗生素市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

15. 食用動物非治療性抗生素市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各國食用動物非治療性抗生素市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Zoetis Inc.
    • Elanco Animal Health Incorporated
    • Merck & Co., Inc.
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale SA
    • Virbac SA
    • Vetoquinol SA
    • Dechra Pharmaceuticals PLC
    • Phibro Animal Health Corporation
    • Huvepharma SA
Product Code: MRR-036C5CF3B529

The Non-Therapeutic Antibiotics for Food Animals Market is projected to grow by USD 9.09 billion at a CAGR of 7.39% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.13 billion
Estimated Year [2025] USD 5.52 billion
Forecast Year [2032] USD 9.09 billion
CAGR (%) 7.39%

A strategic framing of the evolving scientific, regulatory, and commercial context that defines contemporary approaches to non-therapeutic antibiotic use in food animals

The global conversation around non-therapeutic antibiotics in food animal production has entered a more complex phase, shaped by evolving science, shifting consumer expectations, and heightened regulatory scrutiny. Stakeholders across the value chain are contending with the need to reconcile animal health management with antimicrobial stewardship principles, while sustaining productivity and supply continuity. This introduction lays out the context for the analysis that follows, highlighting the interplay between policy developments, industry responses, and commercial realities.

As science increasingly clarifies pathways for resistance and mitigations, producers and suppliers face expectations to adopt responsible use practices and alternatives to routine prophylactic and growth-promotion uses. At the same time, trade and input cost dynamics are influencing procurement and sourcing decisions, prompting supply chain actors to reassess procurement flexibility and supplier relationships. This section establishes a common baseline: non-therapeutic antibiotic use is no longer a narrow veterinary matter but a strategic risk and opportunity that intersects regulatory compliance, brand reputation, animal welfare, and operational resilience.

The remainder of this executive summary builds from this foundation to examine transformative market shifts, tariff-driven trade implications, segmentation-level nuances, regional dynamics, competitive intelligence, recommended actions, and research methodology. Throughout, emphasis is placed on evidence-based decision-making and practical levers organizations can deploy to navigate the transition toward reduced non-therapeutic antibiotic reliance while safeguarding animal productivity and business continuity.

How converging scientific evidence, consumer expectations, and technological advances are transforming stewardship practices and commercial strategies in food animal production

Recent years have seen a sequence of transformative shifts that are reshaping how non-therapeutic antibiotics are perceived, regulated, and used across animal agriculture. First, scientific consensus and surveillance data have elevated antimicrobial resistance from a niche concern to a cross-sectoral public health priority, prompting more robust stewardship frameworks and revised guidelines from veterinary and food safety authorities. Consequently, industry practices are adapting, with many large producers and retailers formalizing antibiotic use policies and accelerating trials of alternative interventions.

Second, consumer preferences are exerting palpable commercial pressure. Increased transparency demands and labeling expectations are incentivizing brands to differentiate through claims about antibiotic use, driving procurement changes and premium positioning for products aligned with stewardship goals. Third, technological advances in husbandry, rapid diagnostics, and vaccine development are expanding the toolkit available to reduce routine prophylactic use and to enable targeted therapeutic interventions. Adoption of these tools, however, varies by production system, scale, and capital intensity.

Finally, supply chain and trade dynamics are evolving in parallel. Vertical integration, contract production models, and retailer-led sourcing requirements are intensifying, while risk management strategies now routinely incorporate regulatory trajectory and reputational exposure. Taken together, these shifts create both operational challenges and strategic openings for firms that can deploy science-based stewardship, demonstrate supply chain traceability, and invest in scalable alternatives to non-therapeutic antibiotic use.

An assessment of how 2025 tariff adjustments have reshaped input sourcing, supply resilience, and the operational feasibility of stewardship investments across the value chain

Tariff policy adjustments enacted in 2025 have introduced additional complexity into the trade and supply equation for inputs and finished products related to animal production, influencing cost structures and sourcing decisions that indirectly affect patterns of non-therapeutic antibiotic use. Tariffs on certain veterinary inputs and on feed ingredient flows have altered relative prices, prompting some producers to reassess procurement geographies and to accelerate supply diversification strategies. These trade shifts are not isolated; they interact with domestic regulatory approaches and farm-level operational choices.

For producers with narrow margins or limited access to alternative inputs, tariff-induced cost pressures can constrain investments in stewardship-enhancing technologies such as rapid diagnostics, enhanced biosecurity infrastructure, or novel vaccine platforms. Conversely, companies with integrated supply chains or greater purchasing scale may seize the moment to reconfigure sourcing toward suppliers offering stewardship-compliant inputs, thereby strengthening long-term competitive positioning. Regional differences in tariff impacts have led to asymmetric responses, with some supply clusters accelerating domestic substitution while others deepen trade partnerships with low-cost suppliers.

Importantly, the tariff landscape has also influenced distributor and feed mill strategies. Distribution networks are adjusting inventories and contract terms to buffer volatility, while feed producers reevaluate formulations to maintain nutritional adequacy amid shifting ingredient prices. In the aggregate, the cumulative tariff effects of 2025 have heightened the strategic premium on resilience and adaptability, making proactive stewardship investments and supply chain redesign ever more salient for actors seeking to manage both compliance and commercial performance.

Segment-specific insights revealing how animal type, product classes, administration modes, end-use intents, formulation formats, and distribution channels determine stewardship pathways and adoption barriers

A granular segmentation lens reveals that pathways away from routine non-therapeutic antibiotic use differ markedly by animal type, product class, application mode, end use, formulation, and sales channel. Based on Animal Type, production systems such as Aquaculture, Cattle, Poultry, and Swine each present distinct epidemiology, management rhythms, and capital requirements that condition feasible stewardship interventions. Poultry and swine systems, which often operate at higher stocking densities and shorter production cycles, face different pressures and opportunities compared with cattle or aquaculture operations.

Based on Product Type, the landscape encompasses broad antibiotic classes including Aminoglycosides, Macrolides, Penicillins, Sulfonamides, and Tetracyclines, each with unique pharmacological properties, withdrawal considerations, and routes of historical use. Within Aminoglycosides, gentamicin, neomycin, and streptomycin have served targeted niches; among Macrolides, erythromycin, tilmicosin, and tylosin remain relevant in specific applications. Penicillins such as amoxicillin, ampicillin, and penicillin G continue to be widely employed therapeutically, while Sulfonamides including sulfadiazine, sulfamethazine, and sulfamethoxazole and Tetracyclines such as chlortetracycline, oxytetracycline, and tetracycline each contribute to distinct treatment paradigms. These product-level differences influence withdrawal planning, regulatory risk profiles, and the attractiveness of alternatives.

Based on Application Mode, the two dominant channels are in-feed and in-water administration, and each presents trade-offs for dosing precision, labor, and potential for lower-intensity prophylactic usage. Based on End Use, distinctions between Growth Promotion and Prophylaxis shape stakeholder incentives and regulatory scrutiny. Based on Formulation, feed additives, oral suspensions, and water soluble powders offer differing logistics, shelf-life, and ease of integration into husbandry routines. Finally, Based on Sales Channel, feed mills, retail pharmacies, and veterinary distributors play distinct roles in shaping access, advisory services, and compliance oversight. Understanding these segmentation layers is essential to designing targeted interventions, prioritizing R&D investments, and tailoring policy measures to the operational realities of different producer cohorts.

How regional regulatory frameworks, trade linkages, and production system diversity across the Americas, Europe Middle East & Africa, and Asia-Pacific shape stewardship trajectories and adoption pathways

Regional dynamics exert a strong influence on regulatory approaches, adoption of alternatives, and trade flows, resulting in differentiated strategic priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, an emphasis on consumer transparency and retailer-led sourcing has driven voluntary stewardship initiatives alongside national regulatory measures. North and South American producers are increasingly aligning procurement practices with buyer requirements and investing in traceability to maintain market access and brand differentiation.

In Europe, Middle East & Africa, regulatory frameworks tend to be prescriptive with firm controls on non-therapeutic uses, and enforcement mechanisms have matured in several European countries. This regulatory rigor has stimulated investment in alternatives, improved on-farm biosecurity practices, and tighter integration of veterinary oversight. By contrast, some MEA markets exhibit uneven regulatory enforcement and variable access to veterinary services, generating pockets of elevated risk and opportunity for targeted capacity-building.

Asia-Pacific encompasses a highly heterogeneous set of production systems and policy environments. Rapidly intensifying livestock sectors in parts of the region have created both pressure points around antibiotic use and fertile grounds for scaled alternative technologies. Trade linkages, feed ingredient sourcing, and input supply chains across the Asia-Pacific region interact with local regulatory trajectories, producing a mosaic of adoption rates and stewardship maturity. Understanding these regional contrasts is critical to designing interventions that are technically feasible, culturally appropriate, and economically sustainable.

Insights on competitive positioning and capability clusters that determine which companies can effectively commercialize alternatives and shape stewardship adoption across supply chains

Competitive dynamics and capability profiles among key industry players are reshaping how stewardship obligations translate into operational choices. Leading integrators and suppliers that combine product innovation with strong distribution networks are better positioned to offer bundled solutions that reduce reliance on routine non-therapeutic antibiotics. These actors typically invest in diagnostic services, vaccination programs, and nutrition-led interventions, enabling customers to transition with lower productivity disruption. Mid-sized regional players often compete on service proximity and pricing, and their success depends on aligning advisory capabilities with local husbandry practices.

Veterinary distributors and feed mill operators play pivotal intermediary roles by influencing on-farm access to products and guidance. Those that evolve from transactional sellers to consultative partners can help accelerate adoption of stewardship-friendly formulations and administration practices. Contract production models and branded retail channels are also important; companies with direct procurement influence can enforce supplier standards and catalyze investment in alternative technologies among upstream partners. New entrants offering rapid diagnostics, biosecurity platforms, or novel therapeutics can disrupt established supply patterns, while incumbent firms with deep customer relationships can leverage scale to commercialize alternatives more rapidly. Across the landscape, the winners will be those that integrate technical credibility, supply chain reach, and tailored commercial models to support customers through transition periods.

Practical, prioritized steps for executives to reduce routine antibiotic reliance while protecting productivity, including diagnostics, procurement realignment, and cross-value-chain collaboration

Industry leaders should prioritize a set of actionable measures that balance immediate compliance needs with longer-term resilience and competitiveness. First, invest in enhanced on-farm advisory services and rapid diagnostics to shift decision-making from blanket prophylaxis to targeted therapeutic interventions. This approach preserves animal health outcomes while reducing unnecessary exposure to antibiotics. Second, develop procurement strategies that diversify input sourcing and favor suppliers that provide verifiable stewardship credentials, thereby mitigating tariff-driven and geopolitical supply risks.

Third, accelerate pilots of non-antibiotic alternatives and husbandry innovations, coupling deployment with rigorous data collection to validate efficacy under commercial conditions. Fourth, strengthen collaboration across the value chain-engaging feed mills, veterinary distributors, retailers, and contract producers-to align incentives, clarify responsibility for compliance, and pool resources for training and infrastructure upgrades. Fifth, embed regulatory intelligence and scenario planning into commercial decision processes so that product portfolios and supply agreements remain adaptable to shifting rules and buyer requirements. Finally, communicate transparently with downstream customers and consumers about stewardship progress to build trust and differentiate responsibly. Implementing these measures requires cross-functional coordination and a mix of short-term operational fixes and sustained capability investments.

A transparent synthesis of literature review, stakeholder interviews, and triangulated qualitative analysis that supports the report's sectoral and operational conclusions

The research underpinning this executive summary combines secondary literature review, stakeholder interviews, and structured qualitative analysis to synthesize contemporary trends affecting non-therapeutic antibiotic use in food animal systems. Secondary sources included peer-reviewed scientific literature, regulatory guidance documents, industry white papers, and public surveillance reports to ensure alignment with the latest evidence on antimicrobial resistance, withdrawal protocols, and stewardship frameworks. Primary inputs were gathered through interviews with veterinarians, feed mill managers, distributor executives, producers across species, and trade specialists to capture operational realities and emergent practices.

Analytical methods prioritized triangulation: findings from interviews were cross-checked against regulatory developments and documented case studies to validate themes and identify divergent regional experiences. The segmentation and regional insights derive from mapping production system characteristics onto product usage patterns, distribution networks, and policy settings. While the methodology emphasizes qualitative depth and practical applicability, care was taken to ensure transparency about sources and to highlight areas where data gaps remain. Readers should consider the conclusions as directional and evidence-based, designed to inform strategy development and operational planning rather than to substitute for bespoke due-diligence in specific commercial contexts.

A conclusive synthesis emphasizing evidence-led strategies and collaborative pathways to reconcile stewardship goals with production and commercial imperatives

In conclusion, the trajectory away from routine non-therapeutic antibiotic use in food animal production is driven by an intersection of scientific, regulatory, commercial, and trade forces. Both risk and opportunity are embedded in this transition: risk in the form of compliance exposure, reputational pressures, and potential cost implications; opportunity in the form of market differentiation, improved animal health outcomes through targeted interventions, and strengthened supply chain resilience. Companies that approach the transition strategically-by investing in diagnostics, diversifying procurement, piloting alternatives, and aligning incentives across the value chain-will be better placed to manage short-term disruptions and secure long-term competitive advantage.

Critical to success will be an evidence-led approach that balances animal welfare, productivity, and public health considerations. Collaboration among producers, advisors, distributors, and buyers will accelerate practical solutions and reduce friction. Finally, iterative assessment of policy trajectories and trade dynamics, combined with flexible operational planning, will enable organizations to adapt as the landscape continues to evolve. The insights in this summary aim to support leaders in charting pragmatic pathways that uphold stewardship commitments while sustaining business performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Expansion of antibiotic stewardship programs driven by retailer mandates and consumer demand for antibiotic-free meat products
  • 5.2. Increasing regulatory restrictions on non-therapeutic antibiotic use in livestock across EU and North America
  • 5.3. Technological innovations in on-farm microbiome monitoring to optimize antibiotic usage reduction strategies
  • 5.4. Rapid adoption of alternative growth promoters such as probiotics and phytogenics in major poultry markets
  • 5.5. Surge of public-private partnerships funding research into antibiotic alternatives for swine production
  • 5.6. Shifts in global meat trade dynamics driven by antibiotic-free certification standards imposed by importers

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Non-Therapeutic Antibiotics for Food Animals Market, by Animal Type

  • 8.1. Aquaculture
  • 8.2. Cattle
  • 8.3. Poultry
  • 8.4. Swine

9. Non-Therapeutic Antibiotics for Food Animals Market, by Product Type

  • 9.1. Aminoglycosides
    • 9.1.1. Gentamicin
    • 9.1.2. Neomycin
    • 9.1.3. Streptomycin
  • 9.2. Macrolides
    • 9.2.1. Erythromycin
    • 9.2.2. Tilmicosin
    • 9.2.3. Tylosin
  • 9.3. Penicillins
    • 9.3.1. Amoxicillin
    • 9.3.2. Ampicillin
    • 9.3.3. Penicillin G
  • 9.4. Sulfonamides
    • 9.4.1. Sulfadiazine
    • 9.4.2. Sulfamethazine
    • 9.4.3. Sulfamethoxazole
  • 9.5. Tetracyclines
    • 9.5.1. Chlortetracycline
    • 9.5.2. Oxytetracycline
    • 9.5.3. Tetracycline

10. Non-Therapeutic Antibiotics for Food Animals Market, by Application Mode

  • 10.1. In Feed
  • 10.2. In Water

11. Non-Therapeutic Antibiotics for Food Animals Market, by End Use

  • 11.1. Growth Promotion
  • 11.2. Prophylaxis

12. Non-Therapeutic Antibiotics for Food Animals Market, by Formulation

  • 12.1. Feed Additives
  • 12.2. Oral Suspensions
  • 12.3. Water Soluble Powders

13. Non-Therapeutic Antibiotics for Food Animals Market, by Sales Channel

  • 13.1. Feed Mills
  • 13.2. Retail Pharmacies
  • 13.3. Veterinary Distributors

14. Non-Therapeutic Antibiotics for Food Animals Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Non-Therapeutic Antibiotics for Food Animals Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Non-Therapeutic Antibiotics for Food Animals Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Zoetis Inc.
    • 17.3.2. Elanco Animal Health Incorporated
    • 17.3.3. Merck & Co., Inc.
    • 17.3.4. Boehringer Ingelheim International GmbH
    • 17.3.5. Ceva Sante Animale S.A.
    • 17.3.6. Virbac S.A.
    • 17.3.7. Vetoquinol S.A.
    • 17.3.8. Dechra Pharmaceuticals PLC
    • 17.3.9. Phibro Animal Health Corporation
    • 17.3.10. Huvepharma S.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AQUACULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AQUACULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AQUACULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GENTAMICIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GENTAMICIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GENTAMICIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GENTAMICIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GENTAMICIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GENTAMICIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NEOMYCIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NEOMYCIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NEOMYCIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NEOMYCIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NEOMYCIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NEOMYCIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STREPTOMYCIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STREPTOMYCIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STREPTOMYCIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STREPTOMYCIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STREPTOMYCIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STREPTOMYCIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ERYTHROMYCIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ERYTHROMYCIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ERYTHROMYCIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ERYTHROMYCIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ERYTHROMYCIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ERYTHROMYCIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TILMICOSIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TILMICOSIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TILMICOSIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TILMICOSIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TILMICOSIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TILMICOSIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TYLOSIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TYLOSIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TYLOSIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TYLOSIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TYLOSIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TYLOSIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMOXICILLIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMOXICILLIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMOXICILLIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMOXICILLIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMOXICILLIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMOXICILLIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMPICILLIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMPICILLIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMPICILLIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMPICILLIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMPICILLIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMPICILLIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLIN G, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLIN G, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLIN G, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLIN G, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLIN G, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLIN G, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFADIAZINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFADIAZINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFADIAZINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFADIAZINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFADIAZINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFADIAZINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHAZINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHAZINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHAZINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHAZINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHAZINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHAZINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHOXAZOLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHOXAZOLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHOXAZOLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHOXAZOLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHOXAZOLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHOXAZOLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CHLORTETRACYCLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CHLORTETRACYCLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CHLORTETRACYCLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CHLORTETRACYCLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CHLORTETRACYCLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CHLORTETRACYCLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY OXYTETRACYCLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY OXYTETRACYCLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY OXYTETRACYCLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY OXYTETRACYCLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY OXYTETRACYCLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY OXYTETRACYCLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN FEED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN FEED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN FEED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN FEED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN FEED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN FEED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN WATER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN WATER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN WATER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN WATER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN WATER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN WATER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROWTH PROMOTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROWTH PROMOTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROWTH PROMOTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROWTH PROMOTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PROPHYLAXIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PROPHYLAXIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PROPHYLAXIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PROPHYLAXIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PROPHYLAXIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PROPHYLAXIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ORAL SUSPENSIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ORAL SUSPENSIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ORAL SUSPENSIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ORAL SUSPENSIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ORAL SUSPENSIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ORAL SUSPENSIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY WATER SOLUBLE POWDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY WATER SOLUBLE POWDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY WATER SOLUBLE POWDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY WATER SOLUBLE POWDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY WATER SOLUBLE POWDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY WATER SOLUBLE POWDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED MILLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED MILLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED MILLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED MILLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED MILLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED MILLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY VETERINARY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY VETERINARY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY VETERINARY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY VETERINARY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY VETERINARY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY VETERINARY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA